Advertisement

Topics

Resverlogix Corp: Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone

07:05 EDT 7 Aug 2018 | FinanzNachrichten

A data review by the independent Data Safety Monitoring Board resulted in a recommendation for the BETonMACE trial to continue as planned without any modificationCALGARY, Alberta" Aug. 07, 2018 (GL...

Original Article: Resverlogix Corp: Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone

NEXT ARTICLE

More From BioPortfolio on "Resverlogix Corp: Resverlogix Announces Seventh Positive Recommendation From The Data Safety Monitoring Board For Phase 3 Study of Apabetalone"

Advertisement
Quick Search
Advertisement
Advertisement